Changes in features of the metabolic syndrome and incident impaired glucose regulation or type 2 diabetes in a Chinese population

Diabetes Care

Volumn 28, Issue 2, 2005, Pages 448-450

  Wang, Jian Jun ^a   Hu, Gang ^a,b   Lappalainen, Jani ^a   Miettinen, Maija E ^a   Qiao, Qing ^a,b   Tuomilehto, Jaakko ^a,b  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANALYSIS OF VARIANCE; ARTICLE; BODY MASS; CONTROLLED STUDY; DISEASE COURSE; DYSLIPIDEMIA; FOLLOW UP; GLUCOSE HOMEOSTASIS; HUMAN; HYPERTENSION; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MANTEL HAENSZEL TEST; MCNEMAR TEST; METABOLIC SYNDROME X; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; RISK FACTOR; STUDENT T TEST;

ADULT; CHINA; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GLUCOSE INTOLERANCE; HUMANS; INCIDENCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED;

EID: 12844254911     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.28.2.448     Document Type: Article

References (11)

1. Haffner SM, Stern MP, Mitchell BD, Hazuda HP, Patterson JK: Incidence of type II diabetes in Mexican Americans predicted by fasting insulin and glucose levels, obesity, and body-fat distribution. Diabetes 39:283-288, 1990
2. Liese AD, Mayer-Davis EJ, Tyroler HA, Davis CE, Keil U, Duncan BB, Heiss G: Development of the multiple metabolic syndrome in the ARIC cohort: joint contribution of insulin, BMI, and WHR. Atherosclerosis Risk in Communities. Ann Epidemiol 7:407-416, 1997
3. Klein BE, Klein R, Lee KE: Components of the metabolic syndrome and risk of cardiovascular disease and diabetes in Beaver Dam. Diabetes Care 25:1790-1794, 2002
4. Carnethon MR, Palaniappan LP, Burchfiel CM, Brancati FL, Fortmann SP: Serum insulin, obesity, and the incidence of type 2 diabetes in black and white adults: the Atherosclerosis Risk in Communities study: 1987-1998. Diabetes Care 25: 1358-1364, 2002
5. Hanson RL, Narayan KM, McCance DR, Pettitt DJ, Jacobsson LT, Bennett PH, Knowler WC: Rate of weight gain, weight fluctuation, and incidence of NIDDM. Diabetes 44:261-266, 1995
6. Saad MF, Knowler WC, Pettitt DJ, Nelson RG, Mott DM, Bennett PH: Sequential changes in serum insulin concentration during development of non-insulin-dependent diabetes. Lancet 1:1356-1359, 1989
7. Weyer C, Bogardus C, Mott DM, Pratley RE: The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 104:787-794, 1999
8. Wang JJ, Qiao Q, Miettinen ME, Lappalainen J, Hu G, Tuomilehto J: The metabolic syndrome defined by factor analysis and incident type 2 diabetes in a Chinese population with high postprandial glucose. Diabetes Care 27:2429-2437, 2004
9. Steering Committee of the Western Pacific Region of the World Health Organization, the International Association for the Study of Obesity, the International Obesity Task Force: The Asia-Pacific perspective: redefining obesity and its treatment. Melbourne, Australia, Health Communications Australia Pty Limited, 2000. Available at http://www.diabetes.com.au/downloads/ obsesity_report.pdf
10. World Health Organization: Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications: Report of a WHO Consultation. Part 1: Diagnosis and Classification of Diabetes and Mellitus. Geneva, World Health Org., 1999 (publ. no. WHO/NCD/NCS/99.2)
11. Balkau B, Charles MA: Comment on the provisional report from the WHO consultation: European Group for the Study of Insulin Resistance (EGIR). Diabet Med 16: 442-443, 1999